U S Physical Therapy (USPH) EBITDA Margin (2010 - 2026)

U S Physical Therapy has disclosed EBITDA Margin across 17 years of filings, most recently posting 10.25% for Q2 2026.

• In Q2 2026, EBITDA Margin fell 238.0% year-over-year to 10.25%; the TTM figure through Jun 2026 stood at 9.42% (down 114.0% YoY), while the FY2025 annual figure was 11.1%, up 172.0% from the prior year.
• EBITDA Margin came in at 10.25% for Q2 2026 at U S Physical Therapy, up from 6.29% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 14.28% in Q2 2022 to a low of 1.57% in Q4 2023.
• Average EBITDA Margin over 5 years is 9.63%, with a median of 10.63% recorded in 2022.
• Year-over-year, EBITDA Margin plunged 787 bps in 2022 and surged 1246 bps in 2024.
• Over 5 years, EBITDA Margin stood at 4.81% in 2022, then sank by 133 bps to 1.57% in 2023, then surged by 794 bps to 10.89% in 2024, then decreased by 24 bps to 8.27% in 2025, then gained by 24 bps to 10.25% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 10.25% in Q2 2026, 6.29% in Q1 2026, and 8.27% in Q4 2025.